Aids killed one person per minute last year, UN report says
UNAIDS pointed out that HIV programmes succeed when public health priorities prevail, as experiences in multiple countries attest.
Source: theeastafrican.co.ke
📰 Oral Prep News
Oral Prep News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Oral Prep. Real-time updates on events, politics, business and more.
Young women prefer vaginal ring to daily oral pill for HIV prevention
Study showed that having a range of options makes it more likely of there being one that will meet an individual’s needs and preferences and that it can and will be used.
South Africa Mitchell Warren Professor Of Global Health International Partnership For Microbicides Microbicide Trials Network Us National Institutes Of Health
Source: theeastafrican.co.ke
ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders, today announced that the US Food and Drug Administration (FDA) approved Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option to reduce the risk of sexually acquired HIV-1.
Source: businesswireindia.com